SEC Filing Details
Document Details
Form
Filing Date
Apr 23, 2018
Document Date
Apr 20, 2018
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aclaris Therapeutics, Inc.
Issuer
Aclaris Therapeutics, Inc.
Filer
Reasons Bryan M